ATE213738T1 - Azaheterocyclische tachykinin rezeptor antagoniste; nk1 und nk2 - Google Patents
Azaheterocyclische tachykinin rezeptor antagoniste; nk1 und nk2Info
- Publication number
- ATE213738T1 ATE213738T1 AT96308711T AT96308711T ATE213738T1 AT E213738 T1 ATE213738 T1 AT E213738T1 AT 96308711 T AT96308711 T AT 96308711T AT 96308711 T AT96308711 T AT 96308711T AT E213738 T1 ATE213738 T1 AT E213738T1
- Authority
- AT
- Austria
- Prior art keywords
- azaheterocyclic
- tachykinin receptor
- receptor antagonists
- receptors
- chem
- Prior art date
Links
- 239000002462 tachykinin receptor antagonist Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 abstract 1
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 abstract 1
- 108010040722 Neurokinin-2 Receptors Proteins 0.000 abstract 1
- 102100037342 Substance-K receptor Human genes 0.000 abstract 1
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31382895 | 1995-12-01 | ||
| JP33636995 | 1995-12-25 | ||
| JP29686996 | 1996-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213738T1 true ATE213738T1 (de) | 2002-03-15 |
Family
ID=27338095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96308711T ATE213738T1 (de) | 1995-12-01 | 1996-12-02 | Azaheterocyclische tachykinin rezeptor antagoniste; nk1 und nk2 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6159967A (de) |
| EP (1) | EP0776893B1 (de) |
| CN (1) | CN1142932C (de) |
| AT (1) | ATE213738T1 (de) |
| AU (1) | AU719158B2 (de) |
| CA (1) | CA2191815C (de) |
| CZ (1) | CZ288498B6 (de) |
| DE (1) | DE69619479T2 (de) |
| DK (1) | DK0776893T3 (de) |
| ES (1) | ES2170211T3 (de) |
| HU (1) | HU224225B1 (de) |
| IL (1) | IL119729A (de) |
| MX (1) | MX9606082A (de) |
| NO (1) | NO308300B1 (de) |
| NZ (1) | NZ299859A (de) |
| PT (1) | PT776893E (de) |
| RU (1) | RU2135494C1 (de) |
| TW (1) | TW367327B (de) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2135494C1 (ru) * | 1995-12-01 | 1999-08-27 | Санкио Компани Лимитед | Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина |
| EP0987269B1 (de) | 1997-05-30 | 2003-08-13 | Sankyo Company Limited | Salze von optisch aktiven sulfoxid-derivaten |
| CA2312770A1 (en) | 1997-12-04 | 1999-06-10 | Takahide Nishi | Alicyclic acylated heterocyclic derivatives |
| EP1057827B1 (de) | 1998-01-23 | 2003-09-10 | Sankyo Company Limited | Spiropiperidin-derivate |
| WO2000034274A1 (en) * | 1998-12-10 | 2000-06-15 | Sankyo Company, Limited | Cyclohexylpiperidine derivatives |
| US6867203B2 (en) | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| FR2791346B3 (fr) * | 1999-03-25 | 2001-04-27 | Sanofi Sa | Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2796069B3 (fr) * | 1999-07-09 | 2001-08-24 | Sanofi Synthelabo | Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes |
| AU7952800A (en) * | 1999-10-22 | 2001-04-30 | Sankyo Company Limited | 2-alkoxybenzene derivatives |
| MXPA02004330A (es) | 1999-11-03 | 2004-07-30 | Albany Molecular Res Inc | Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.. |
| US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
| AU7334901A (en) | 2000-07-11 | 2002-01-21 | Du Pont Pharm Co | Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| FR2824828B1 (fr) * | 2001-05-21 | 2005-05-20 | Sanofi Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
| US7396930B2 (en) * | 2002-06-11 | 2008-07-08 | Sankyo Company, Limited | Process for producing cyclic thioether and synthetic intermediate thereof |
| JP2004067673A (ja) * | 2002-06-11 | 2004-03-04 | Sankyo Co Ltd | 環状チオエーテル類の製造法及びその合成中間体 |
| AU2003242092A1 (en) * | 2002-06-11 | 2003-12-22 | Sankyo Company, Limited | Process for producing cyclic thioether and synthetic intermediate thereof |
| MY141736A (en) * | 2002-10-08 | 2010-06-15 | Elanco Animal Health Ireland | Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists |
| CA2503520A1 (en) * | 2002-10-24 | 2004-05-06 | Sankyo Company Limited | Process for producing optically active sulfoxide |
| EP1754701A4 (de) * | 2004-02-25 | 2007-10-03 | Sankyo Co | Sulfonyloxyderivate |
| CN1922173A (zh) | 2004-02-25 | 2007-02-28 | 三共株式会社 | 茚满醇衍生物 |
| BRPI0513359A (pt) | 2004-07-15 | 2008-05-06 | Amr Technology Inc | tetraidroisoquinolinas substituìdas por arila e heteroarila e uso destes para bloquear a recaptação de norepinefrina, dopamina, e serotonina |
| FR2873373B1 (fr) * | 2004-07-23 | 2006-09-08 | Sanofi Synthelabo | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
| CN101031296A (zh) * | 2004-08-19 | 2007-09-05 | 弗特克斯药品有限公司 | 毒蕈碱受体调节剂 |
| EP1888050B1 (de) | 2005-05-17 | 2012-03-21 | Merck Sharp & Dohme Ltd. | Cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropansäure zur Behandlug von Krebs |
| UA95454C2 (uk) | 2005-07-15 | 2011-08-10 | Амр Текнолоджи, Інк. | Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну |
| EP2314295B1 (de) | 2005-07-29 | 2015-01-28 | Resverlogix, Inc | Arzneimittel zur Prävention und Behandlung komplexer Erkrankungen und deren Freisetzung mittels einsetzbarer Medizinprodukte |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| CN101190330A (zh) | 2006-11-30 | 2008-06-04 | 深圳市鼎兴生物医药技术开发有限公司 | 胆碱酯酶在拮抗速激肽药物中的应用 |
| AR064777A1 (es) | 2007-01-10 | 2009-04-22 | Inst Di Reserche D Biolog Mole | Indazoles sustituidos con amida como inhibidores de poli (adp- ribosa) polimerasa (parp) |
| WO2008094663A2 (en) * | 2007-01-31 | 2008-08-07 | Adam Heller | Electrochemical management of pain |
| CA2676984C (en) | 2007-02-01 | 2015-03-17 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
| AU2008269154B2 (en) | 2007-06-27 | 2014-06-12 | Merck Sharp & Dohme Llc | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| AR071997A1 (es) | 2008-06-04 | 2010-07-28 | Bristol Myers Squibb Co | Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina |
| CA2711103C (en) | 2008-06-26 | 2016-08-09 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
| AU2010204106B2 (en) | 2009-01-08 | 2014-05-08 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| WO2010106436A2 (en) | 2009-03-18 | 2010-09-23 | Resverlogix Corp. | Novel anti-inflammatory agents |
| US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
| AU2010239266B2 (en) | 2009-04-22 | 2015-01-22 | Resverlogix Corp. | Novel anti-inflammatory agents |
| CN102638982B (zh) | 2009-05-12 | 2015-07-08 | 百时美施贵宝公司 | (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途 |
| EP2429296B1 (de) | 2009-05-12 | 2017-12-27 | Albany Molecular Research, Inc. | 7-([1,2,4,]triazol[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorphenyl)-1,2,3,4- tetrahydroisochinolin und seine verwendung |
| MX2011011901A (es) | 2009-05-12 | 2012-01-20 | Albany Molecular Res Inc | Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas. |
| AU2010307198B9 (en) | 2009-10-14 | 2014-02-13 | Merck Sharp & Dohme Corp. | Substituted piperidines that increase p53 activity and the uses thereof |
| JP6043285B2 (ja) | 2010-08-02 | 2016-12-14 | サーナ・セラピューティクス・インコーポレイテッドＳｉｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 低分子干渉核酸（ｓｉＮＡ）を用いたカテニン（カドヘリン結合型タンパク質）β１（ＣＴＮＮＢ１）遺伝子発現のＲＮＡ干渉媒介性阻害 |
| LT2606134T (lt) | 2010-08-17 | 2019-07-25 | Sirna Therapeutics, Inc. | Hepatito b viruso (hbv) geno raiškos slopinimas, tarpininkaujant rnr interferencijai naudojant mažą interferuojančią nukleorūgštį (sina) |
| EP2608669B1 (de) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer |
| US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| EP2615916B1 (de) | 2010-09-16 | 2017-01-04 | Merck Sharp & Dohme Corp. | Kondensierte pyrazolderivate als neue erk-hemmer |
| WO2012058210A1 (en) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA) |
| EP2654748B1 (de) | 2010-12-21 | 2016-07-27 | Merck Sharp & Dohme Corp. | Indazolderivate als erk-hemmer |
| EP2699568A1 (de) | 2011-04-21 | 2014-02-26 | Piramal Enterprises Limited | Kristalline form eines morpholinsulfonylindolderivat-salzes und verfahren zu seiner herstellung |
| EP2770987B1 (de) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Neue verbindungen als erk-hemmer |
| CA2851996C (en) | 2011-11-01 | 2020-01-07 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
| EP3453762B1 (de) | 2012-05-02 | 2021-04-21 | Sirna Therapeutics, Inc. | Sina-zusammensetzungen |
| EP2900241B1 (de) | 2012-09-28 | 2018-08-08 | Merck Sharp & Dohme Corp. | Neuartige verbindungen als erk-hemmer |
| BR102012024778A2 (pt) * | 2012-09-28 | 2014-08-19 | Cristalia Prod Quimicos Farm | Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| AU2013352568B2 (en) | 2012-11-28 | 2019-09-19 | Merck Sharp & Dohme Llc | Compositions and methods for treating cancer |
| ES2707305T3 (es) | 2012-12-20 | 2019-04-03 | Merck Sharp & Dohme | Imidazopiridinas sustituidas como inhibidores de HDM2 |
| US9271978B2 (en) | 2012-12-21 | 2016-03-01 | Zenith Epigenetics Corp. | Heterocyclic compounds as bromodomain inhibitors |
| US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
| EP3041938A1 (de) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Kreisförmige polynukleotide |
| WO2016147053A1 (en) | 2015-03-13 | 2016-09-22 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
| WO2018071283A1 (en) | 2016-10-12 | 2018-04-19 | Merck Sharp & Dohme Corp. | Kdm5 inhibitors |
| US11098059B2 (en) | 2017-11-08 | 2021-08-24 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
| WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| US11993602B2 (en) | 2018-08-07 | 2024-05-28 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| WO2020033284A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| US12173026B2 (en) | 2018-08-07 | 2024-12-24 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| CN113194948A (zh) * | 2018-11-15 | 2021-07-30 | 国立大学法人九州大学 | Il-31介导性疾病的预防或治疗剂及医药组合物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical compositions containing them |
| FR2676054B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| WO1993012115A1 (en) | 1991-12-18 | 1993-06-24 | Gruppo Lepetit S.P.A. | 7'-amino-naphthazarin antibiotic derivatives |
| AU693087B2 (en) * | 1993-01-28 | 1998-06-25 | Merck & Co., Inc. | Spiro-substituted azacycles as tachykinin receptor antagonists |
| HU224496B1 (hu) * | 1993-05-06 | 2005-10-28 | Merrel Dow Pharmaceuticals Inc. | Pirrolidin-3-il-alkil-piperidin-származékok és e vegyületeket tartalmazó gyógyászati készítmények |
| GB9310713D0 (en) * | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| JPH08511522A (ja) * | 1993-06-07 | 1996-12-03 | メルク エンド カンパニー インコーポレーテッド | ニューロキニンアンタゴニストとしてのスピロ置換アザ環 |
| FR2719311B1 (fr) * | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
| AU2223495A (en) * | 1994-04-15 | 1995-11-10 | Yamanouchi Pharmaceutical Co., Ltd. | Spiro compound and medicinal composition thereof |
| FR2729952B1 (fr) * | 1995-01-30 | 1997-04-18 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2729951B1 (fr) * | 1995-01-30 | 1997-04-18 | Sanofi Sa | Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| RU2135494C1 (ru) * | 1995-12-01 | 1999-08-27 | Санкио Компани Лимитед | Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина |
| JP3192631B2 (ja) * | 1997-05-28 | 2001-07-30 | 三共株式会社 | 飽和複素環化合物からなる医薬 |
-
1996
- 1996-11-29 RU RU96122851A patent/RU2135494C1/ru not_active IP Right Cessation
- 1996-11-29 HU HU9603298A patent/HU224225B1/hu not_active IP Right Cessation
- 1996-11-30 TW TW085114815A patent/TW367327B/zh not_active IP Right Cessation
- 1996-12-01 IL IL11972996A patent/IL119729A/en not_active IP Right Cessation
- 1996-12-01 CN CNB961238887A patent/CN1142932C/zh not_active Expired - Fee Related
- 1996-12-02 ES ES96308711T patent/ES2170211T3/es not_active Expired - Lifetime
- 1996-12-02 CA CA002191815A patent/CA2191815C/en not_active Expired - Fee Related
- 1996-12-02 AT AT96308711T patent/ATE213738T1/de not_active IP Right Cessation
- 1996-12-02 EP EP96308711A patent/EP0776893B1/de not_active Expired - Lifetime
- 1996-12-02 US US08/758,421 patent/US6159967A/en not_active Expired - Fee Related
- 1996-12-02 AU AU74065/96A patent/AU719158B2/en not_active Ceased
- 1996-12-02 NZ NZ299859A patent/NZ299859A/xx unknown
- 1996-12-02 PT PT96308711T patent/PT776893E/pt unknown
- 1996-12-02 MX MX9606082A patent/MX9606082A/es not_active IP Right Cessation
- 1996-12-02 NO NO965125A patent/NO308300B1/no not_active IP Right Cessation
- 1996-12-02 DE DE69619479T patent/DE69619479T2/de not_active Expired - Lifetime
- 1996-12-02 CZ CZ19963521A patent/CZ288498B6/cs not_active IP Right Cessation
- 1996-12-02 DK DK96308711T patent/DK0776893T3/da active
-
2000
- 2000-03-22 US US09/533,061 patent/US6448247B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| TW367327B (en) | 1999-08-21 |
| HU224225B1 (hu) | 2005-06-28 |
| EP0776893B1 (de) | 2002-02-27 |
| CZ288498B6 (en) | 2001-06-13 |
| DE69619479D1 (de) | 2002-04-04 |
| NO308300B1 (no) | 2000-08-28 |
| MX9606082A (es) | 1998-08-30 |
| AU7406596A (en) | 1997-06-05 |
| CN1142932C (zh) | 2004-03-24 |
| IL119729A0 (en) | 1997-03-18 |
| AU719158B2 (en) | 2000-05-04 |
| US6448247B1 (en) | 2002-09-10 |
| US6159967A (en) | 2000-12-12 |
| CN1157286A (zh) | 1997-08-20 |
| NO965125L (no) | 1997-06-02 |
| NO965125D0 (no) | 1996-12-02 |
| DE69619479T2 (de) | 2002-10-17 |
| CZ352196A3 (en) | 1997-06-11 |
| CA2191815C (en) | 2005-05-10 |
| PT776893E (pt) | 2002-06-28 |
| ES2170211T3 (es) | 2002-08-01 |
| RU2135494C1 (ru) | 1999-08-27 |
| HK1011366A1 (en) | 1999-07-09 |
| IL119729A (en) | 2001-07-24 |
| HU9603298D0 (en) | 1997-01-28 |
| DK0776893T3 (da) | 2002-03-18 |
| EP0776893A1 (de) | 1997-06-04 |
| HUP9603298A2 (hu) | 1998-09-28 |
| CA2191815A1 (en) | 1997-06-02 |
| HUP9603298A3 (en) | 1999-10-28 |
| NZ299859A (en) | 1997-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69619479D1 (de) | Azaheterocyclische Tachykinin Rezeptor Antagoniste; NK1 und NK2 | |
| DE69615700D1 (de) | 1-(1,2-disubstituierte piperidinyl)-4-substituierte piperidin derivate als tachykinin receptor antagonisten | |
| DK0804419T3 (da) | Quinolinderivater som tachykinin NK 3-receptor-antagonister | |
| DE69127791D1 (de) | Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten | |
| FI970107A7 (fi) | Heterosyklisiä takykiniinireseptoriantagonisteja | |
| NO974686D0 (no) | Nye substituerte piperazinderivater med tachykinin reseptor antagonist aktivitet | |
| ATE201016T1 (de) | Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten | |
| NO996178L (no) | 4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister | |
| DK1129091T3 (da) | Antagonister for CRF-receptorer og fremgangsmåder med relation dertil | |
| TR200000025T2 (tr) | Azetidinilpropilpiperidin türevleri, ara bağlarıyla tacikinin antagonistleri olarak kullanımları. | |
| DE69939053D1 (de) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives als muskarin-rezeptor antagonisten | |
| AU1667500A (en) | N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists | |
| ATE277901T1 (de) | Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten | |
| ATE234098T1 (de) | 4-aminopyrrole (3,2-d) pyrimidinen als antagonisten des neuropeptide y receptors | |
| DK0815105T3 (da) | Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister | |
| DE69617010D1 (de) | Isazole derivate als fibrinogen-rezeptor-antagonisten | |
| FI943872L (fi) | 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina | |
| EA199800204A1 (ru) | Антагонисты 5-нтрецепторов для лечения дискинезии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |